Core 1: Tumor Processing and Single Cell RNA sequencing Core

核心1：肿瘤处理和单细胞RNA测序核心

• 批准号: 10684050
• 负责人: Kai W Wucherpfennig
• 金额: $ 34.98万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-03 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10684050
• 关键词: Animal Model; Blood; Brain Neoplasms; Cell Separation; Cells; Clinical; Clinical Trials; Clonal Expansion; Combination immunotherapy; Complement; Complex; DNA Sequencing Facility; Data; Data Set; Diagnosis; Ecosystem; Ensure; Epigenetic Process; Equipment; Experimental Models; Flow Cytometry; Gene Expression; Genetic; Genetic Transcription; Genomics; Genotype; Glioblastoma; Goals; Heterogeneity; Human; Human Resources; Immune; Immunologics; Immunosuppression; Immunotherapy; Individual; Knowledge; Length; Malignant Neoplasms; Methods; Molecular Immunology; Myeloid Cells; Operative Surgical Procedures; Pathway interactions; Patients; Peptide Vaccines; Phase; Population; Premalignant Cell; Quality Control; Reagent; Recurrence; Recurrent tumor; Regulatory Pathway; Relapse; Reproducibility; Research Personnel; Resolution; Resources; Sampling; Services; Specimen; Standardization; T cell infiltration; T-Lymphocyte; Techniques; Technology; Testing; Transcript; anti-PD1 antibodies; antigen-specific T cells; cancer cell; cancer infiltrating T cells; conventional therapy; data sharing; genetic information; mouse model; neoantigen vaccine; neoantigens; novel therapeutic intervention; participant enrollment; programs; single cell technology; single-cell RNA sequencing; success; technology platform; tool; transcriptome; tumor

Abstract Single cell RNA-sequencing (scRNA-seq) has emerged as a powerful approach to dissect tumors and their ecosystems by determining the state of individual cells and inferring partial genetic information from expressed transcripts. For infiltrating T cells, this provides a comprehensive approach to define T cell states in human tumors. For malignant cells, scRNA-seq paves the way to characterizing cellular states and their associated genotypes at cellular resolution. The Molecular Immunology Core (Core 1) provides standardized and reproducible methods to profile and characterize immune cells and malignant cells by scRNA-seq in glioblastoma in both patients and mouse models. Core 1 also provides expert personnel, facilitates the sharing of knowledge within the program, and maintain the sophisticated equipment necessary to generate data for all Projects. The Molecular Immunology Core will be led Dr. Mario Suvà and Dr. Kai Wucherpfennig who will contribute their expertise in single-cell technologies and immune cell isolation.

摘要 单细胞RNA测序（scRNA-seq）已经成为一种强大的方法来解剖肿瘤， 通过确定单个细胞的状态和推断部分遗传信息， 从表达的文字记录中。对于浸润性T细胞，这提供了一种全面的方法来定义T细胞。 人类肿瘤中的细胞状态。对于恶性细胞，scRNA-seq铺平了表征细胞 状态及其相关的基因型在细胞分辨率。分子免疫学核心（Core 1） 提供标准化和可重复的方法来分析和表征免疫细胞， 在患者和小鼠模型中，通过scRNA-seq在胶质母细胞瘤中检测恶性细胞。核心1 提供专家人员，促进计划内的知识共享，并维护 为所有项目生成数据所需的先进设备。分子免疫学核心 将由Mario Suvà博士和Kai Wucherpfennig博士领导，他们将贡献他们在单细胞 技术和免疫细胞分离。